PI3K-Akt/PKB signaling pathway in neutrophils and mononuclear cells exposed to N-nitrosodimethylamine

Journal of Immunotoxicology

Volumn 11, Issue 3, 2014, Pages 231-237

  Ratajczak Wrona, Wioletta ^a   Jablonska, Ewa ^a   Garley, Marzena ^a   Jablonski, Jakub ^a   Radziwon, Piotr ^b   Iwaniuk, Agnieszka ^a   Grubczak, Kamil ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Centre for Transfusion Medicine   (Poland)

Author keywords

AP 1; Inducible nitric oxide synthase; Mononuclear cells; Neutrophils; NF B; Nitric oxide; PI3K Akt PKB

Indexed keywords

DIMETHYLNITROSAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; TRANSCRIPTION FACTOR FOSB; WORTMANNIN; ANDROSTANE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; XENOBIOTIC AGENT;

ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; OCCUPATIONAL EXPOSURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PHOSPHORYLATION; TRANSCRIPTION INITIATION; UPREGULATION;

ANDROSTADIENES; CELLS, CULTURED; DIMETHYLNITROSAMINE; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTROPHILS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; XENOBIOTICS;

EID: 84903118526     PISSN: 1547691X     EISSN: 15476901     Source Type: Journal    
DOI: 10.3109/1547691X.2013.826307     Document Type: Article

References (46)

1. Beck, K. F., Eberhardt, W., Frank, S., et al. 1999. Inducible NO synthase: Role in cellular signaling. J. Exp. Biol. 202:645-653.
2. Belinsky, S. A., Devereux, T. R., and Anderson, M. W. 1990. Role of DNA methylation in the activation of proto-oncogenes and the induction of pulmonary neoplasia by nitrosamines. Mutat. Res. 233: 105-116.
3. Bonizzi, G., and Karin, M. 2004. The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25: 280-288.
4. Brendler, S. Y., Tompa, A., Hutter, K. F., et al. 1992. In vivo and in vitro genotoxicity of several N-nitrosamines in extra-hepatic tissues of the rat. Carcinogenesis. 13:2435-2441.
5. D́iaz-Guerra, M. J., Castrillo, A., Mart́in-Sanz, P., and Boscá, L. 1999. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162: 6184-6190
6. Foletta, V. C., Segal, D. H., and Cohen, D. R. 1998. Transcriptional regulation in the immune system: All roads lead to AP-1. J. Leukocyte Biol. 63:139-152.
7. Foster, F. M., Traer, C. J., Abraham, S. M., and Fry, M. J. 2003. The phosphoinositide (PI) 3-kinase family. J. Cell Sci. 116:3037-3040.
8. Fussgaenger, R. D., and Ditschuneit, H. 1980. Lethal exitus of a patient with N-nitrosodimethylamine poisoning, 2.5 years following the first ingestion and signs of intoxication. Oncology. J. 37:273-277.
9. Hanada, M., Feng, J., and Hemmings, B. A. 2004. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim. Biophys. Acta 1697:3-16.
10. Hawkins, P. T., Stephens, L. R., Suire, S., and Wilson, M. 2010. PI3K signaling in neutrophils. Curr. Top. Microbiol. Immunol. 346: 183-202.
11. Hayden, M. S., and Ghosh, S. 2004. Signaling to NF-kB. Gene Dev. 18: 2195-2224.
12. Holsapple, M. P., Bick, P. H., and Duke, S. S. 1985. Effects of N-nitrosodimethylamine on cell mediated immunity. J. Leukocyte Biol. 37:367-381.
13. Jablonska, E., Jablonski, J., and Pietruska, Z. 1996. Function of neutrophils (PMN) in nitrosodimethylamine (NDMA)-exposed rats. Bromatol. Chem. Toksykol. 29:85-89.
14. Jablonski, J., Jablonska, E., and Leonik, A. 2011. The effect of N-nitrosodimethylamine (NDMA) on Bax and Mcl-1 expression in human neutrophils. Environ. Contam. Tox. 87:638-642.
15. Jablonski, J., Jablonska, E., and Moniuszko-Jakoniuk, J. 2007. The effect of N-nitrosodimethylamine on TRAIL and DR5 expression in human neutrophils: Preliminary study. Immunopharmacol. Immunotoxicol. 29: 287-296.
16. Jakubowicz-Gil, J. 2009. Inhibitors of PI3K-Akt/PKB-mTOR pathway in glioma therapy. Post. Biol. Kom. 36:189-201.
17. Jiao, J., Glickman, B. W., Anderson, M. W., and Zielinska, M. 1993. Mutational specificity of N-nitrosodimethylamine: Comparison between in vivo and in vitro assays. Mutat. Res. 301:27-31.
18. Karin, M., Liu, Z., and Zandi, E. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246.
19. Koyasu, S. 2003. The role of PI3K in immune cells. Nat. Immunol. 4: 313-319.
20. Kristof, A. S., Fielhaber, J., Triantafillopoulos, A., et al. 2006. Phosphatidyl-inositol 3-kinase-dependent suppression of the human inducible nitric-oxide synthase promoter is mediated by FKHRL1. J. Biol. Chem. 281:23958-23968.
21. Kroncke, K. D., Fehsel, K., and Kolb-Bachofen, V. 1995. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol. Chem. H-S. 376: 327-343.
22. Lijinsky, W. (Ed.). 1992. Chemistry and biology of N-nitroso compounds. Cambridge: University Press Cambridge.
23. Lirk, P., Hoffmann, G., and Rieder, J. 2002. Inducible nitric oxide synthase; Time for reappraisal. Curr. Drug Targets 1:89-108.
24. Manning, B. D., and Cantley, L. C. 2007. AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274.
25. Mantovani, A., Cassatella, M. A., Costantini, C., and Jaillon, S. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11:519-531.
26. Moodley, Y. P. 2002. The role of inducible nitric oxide in health and disease. Curr. Diag. Pathol. 8:297-304.
27. Nishikori, M. 2005. Classical and alternative NF-kB activation pathways and their roles in lymphoid malignancies. J. Clin. Exp. Hematopathol. 45:15-24.
28. Nworu, C. S., Akah, P. A., Okoye, F. B., et al. 2011. The leaf extract of Spondias mombin L. displays an anti-inflammatory effect and suppresses inducible formation of tumor necrosis factor-a and nitric oxide (NO). J. Immunotoxicol. 8:10-16.
29. Okhrimenko, H., Lu, W., Xiang, C, et al. 2005. Protein kinase CE regulates the apoptosis and survival of glioma cells. Cancer Res. 65: 7301-7319.
30. Pedal, I., Besserer, K., Goerttler, K., et al. 1982. Fatal nitrosamine poisoning. Arch. Toxicol. 50:101-112.
31. Perkins, N. D. 2007. Integrating cell-signaling pathways with NF-KB and IKK function Mol. Cell Biol. 8:49-62.
32. Ratajczak-Wrona, W., Jablonska, E., Garley, M., et al. 2011. Effect of N-nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: The role of JNK signaling pathway. APMIS. 119:431-441.
33. Ratajczak-Wrona, W., Jablonska, E., Garley, M., et al. 2013a. Role of AP-1 family proteins in regulation of inducible nitric oxide synthase (iNOS) in human neutrophils. J. Immunotoxicol. 10:32-39.
34. Ratajczak-Wrona, W., Jablonska, E., Garley, M., et al. 2013b. The role of MAP kinases in the induction of iNOS expression in neutrophils exposed to NDMA: The involvement transcription factors. Adv. Med. Sci. 58:(In Press-the print version will be published in December 2013 in Volume 58).
35. Ratajczak-Wrona, W, Jablonska, E., Garley, M., et al. 2013c. Activation of the JAK/STAT pathway in human neutrophils by NDMA. Turk. J. Biol. (In Press; Available online at: http://mistug.tubitak.gov.tr/bdyim/kabul.php?dergi=biy).
36. Romashkova, J. A., and Makarov, S. S. 1999. NF-KB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.
37. Sakai, K, Suzuki, H., Oda, H., et al. 2006. Phosphoinositide 3-kinase in nitric oxide synthesis in macrophages: Critical dimerization of inducible nitric-oxide synthase. J. Biol. Chem. 281:17736-17742.
38. Schulz, K, Kerber, S., and Kelm, M. 1999. Reevaluation of the Griess method for determining NO/NO2-in aqueous and protein containing samples. NO-Biol. Chem. 3:225-234.
39. Shaulian, E., and Karin, M. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-136
40. Souliotis, V. L., van Delft, J. H., Steenwinkel, M. J., et al. 1998. DNA adducts, mutant frequencies and mutation spectra in A lacZ transgenic mice treated with N-nitrosodimethylamine. Carcinogenesis 19:731-739.
41. Tricker, A. R., and Preussmann, R. 1991. Carcinogenic N-nitrosamines in the diet: Occurrence, formation, mechanisms, and carcinogenic potential. Mutat. Res. 259:277-289.
42. Wright, K, Ward, S. G, Kolios, G, and Westwick J. 1997. Activation of phosphatidylinositol 3-kinase by Interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J. Biol. Chem. 272:12626-12633.
43. Wu, S., Tan, M., Hu, Y., et al. 2004. Ultraviolet light activates NF-KB through translational inhibition of IKB synthesis. J. Biol. Chem. 279: 24898-24902.
44. Wu, Z. H., and Miyamoto, S. 2007. Many faces of NF-KB signaling induced by genotoxic stress. J. Mol. Med. (Berlin). 85:1187-1202.
45. Xia, X., Hu, X., Xu, H., et al. 2012. Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats. Mol. Cell. Biochem. 359: 293-299.
46. Zeman, K, Tchorzewski, H., and Majewska, E. 1988. Simple and fast method of simultaneous isolation of lymphocytes and the polymorphonuclear cells from peripheral blood. Immunol. Pol. 13:217-220.